|
TMED8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.103600E-03 |
| Normal-vs-Stage3 |
6.22502049907325E-13 |
| Normal-vs-Stage4 |
1.64313007644523E-12 |
| Stage1-vs-Stage2 |
9.703700E-03 |
| Stage1-vs-Stage3 |
4.013200E-01 |
| Stage1-vs-Stage4 |
9.257300E-03 |
| Stage2-vs-Stage3 |
4.843800E-03 |
| Stage2-vs-Stage4 |
1.183780E-04 |
| Stage3-vs-Stage4 |
7.474100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.62673999999363E-05 |
| Normal-vs-Asian |
2.20712337295481E-13 |
| Caucasian-vs-AfricanAmerican |
4.717200E-01 |
| Caucasian-vs-Asian |
1.370180E-01 |
| AfricanAmerican-vs-Asian |
1.372760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.20967688591145E-12 |
| Normal-vs-Female |
1.62481139653892E-12 |
| Male-vs-Female |
6.589000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
4.42612613227311E-12 |
| Normal-vs-Age(61-80Yrs) |
4.90909979333765E-10 |
| Normal-vs-Age(81-100Yrs) |
6.435900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.773000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.045580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.780400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.852200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.409600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.705000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.82170000000626E-05 |
| Classical-VS-Follicular |
4.4420000000045E-05 |
| Classical-VS-Other |
8.342600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
3.45359962850011E-10 |
| Tall-VS-Other |
2.459600E-02 |
| Tall-VS-Normal |
1.62470037423645E-12 |
| Follicular-VS-Other |
2.494800E-01 |
| Follicular-VS-Normal |
4.604300E-04 |
| Other-VS-Normal |
3.540300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.40850014879379E-10 |
| Normal-vs-N1 |
1.62536650805123E-12 |
| N0-vs-N1 |
1.59167000000071E-05 |
|
|
